IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CHIGHIZOLA, CECILIA BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.732
AS - Asia 6.463
EU - Europa 5.074
SA - Sud America 639
AF - Africa 164
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.297
CN - Cina 2.021
SG - Singapore 1.905
GB - Regno Unito 1.240
IT - Italia 1.101
HK - Hong Kong 615
DE - Germania 594
BD - Bangladesh 555
VN - Vietnam 520
RU - Federazione Russa 470
SE - Svezia 450
BR - Brasile 420
FR - Francia 305
CA - Canada 294
IN - India 213
IE - Irlanda 175
NL - Olanda 142
FI - Finlandia 133
ES - Italia 119
KR - Corea 103
JP - Giappone 102
ID - Indonesia 95
MX - Messico 89
TR - Turchia 89
AR - Argentina 73
CO - Colombia 59
CI - Costa d'Avorio 46
UA - Ucraina 45
BE - Belgio 42
PL - Polonia 42
DK - Danimarca 38
AT - Austria 31
AU - Australia 28
GR - Grecia 28
PK - Pakistan 28
CH - Svizzera 27
ZA - Sudafrica 26
EC - Ecuador 25
PH - Filippine 24
SA - Arabia Saudita 23
EG - Egitto 22
IQ - Iraq 21
CL - Cile 20
TH - Thailandia 18
UZ - Uzbekistan 16
MY - Malesia 14
TW - Taiwan 14
EU - Europa 13
PT - Portogallo 13
KE - Kenya 12
NO - Norvegia 12
PE - Perù 12
IL - Israele 11
MA - Marocco 11
VE - Venezuela 11
CR - Costa Rica 10
LT - Lituania 10
PY - Paraguay 10
RO - Romania 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
DZ - Algeria 8
HN - Honduras 8
JO - Giordania 8
TN - Tunisia 8
TT - Trinidad e Tobago 7
BY - Bielorussia 6
HR - Croazia 6
HU - Ungheria 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
OM - Oman 6
RS - Serbia 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
ET - Etiopia 5
IR - Iran 5
KZ - Kazakistan 5
DO - Repubblica Dominicana 4
GE - Georgia 4
LB - Libano 4
LU - Lussemburgo 4
NG - Nigeria 4
NI - Nicaragua 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
SC - Seychelles 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
Totale 19.086
Salva come PNG Salva come JPEG
Città #
Singapore 1.028
Southend 998
Ashburn 743
Hong Kong 516
San Jose 440
Chandler 364
Beijing 361
Milan 311
Dallas 309
Santa Clara 267
Council Bluffs 244
New York 218
Los Angeles 191
Princeton 183
Seattle 180
Wilmington 173
Munich 167
Dublin 165
Fairfield 161
Ho Chi Minh City 150
Frankfurt am Main 148
Hefei 145
Hangzhou 142
Hanoi 133
Houston 129
Lauterbourg 127
Montréal 109
Dearborn 108
Guangzhou 104
Buffalo 102
Ann Arbor 100
Bengaluru 92
Woodbridge 88
Mcallen 87
Moscow 85
Nanjing 83
Toronto 78
Shanghai 77
Cambridge 74
Redwood City 73
Boardman 70
Rome 68
Des Moines 67
Jakarta 65
Helsinki 60
Phoenix 57
Sunnyvale 52
Abidjan 46
Seoul 46
The Dalles 44
Tianjin 43
Tokyo 43
Columbus 42
São Paulo 42
London 38
Jinan 37
Madrid 36
Cangzhou 34
Grafing 34
Shenzhen 34
Nuremberg 32
Mountain View 31
Turin 31
Shenyang 29
Berlin 28
Falls Church 28
Changsha 27
Redmond 27
Naples 26
Da Nang 25
Montreal 24
Bogotá 23
Chicago 22
Hebei 22
Atlanta 21
Brussels 21
Jiaxing 19
Medford 19
Ottawa 19
Turku 19
Buenos Aires 18
Mexico City 18
Zhengzhou 18
Fuzhou 17
Istanbul 17
Rio de Janeiro 17
Athens 16
Jacksonville 16
Johannesburg 16
Tashkent 16
Warsaw 16
Chengdu 15
Mumbai 15
Paris 15
Stockholm 15
Vienna 15
Wuhan 15
Zurich 15
Bologna 14
Brooklyn 14
Totale 11.022
Salva come PNG Salva come JPEG
Nome #
Management of Thrombotic Antiphospholipid Syndrome 781
The role of environmental estrogens and autoimmunity 635
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications 549
THE PATHOGENIC ROLE OF IMMUNE COMPLEXES CONTAINING SCLERODERMA-SPECIFIC AUTOANTIBODIES 354
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 349
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome 318
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis : "Pros" and "Cons" 304
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies 283
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 262
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers 259
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 256
Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies 255
Treatment of Thrombotic Antiphospholipid Syndrome : The Rationale of Current Management - An Insight into Future Approaches 252
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19) 250
Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis 229
The geoepidemiology of autoimmune liver disease 227
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts 216
Antiphospholipid antibody profile stability over time: Prospective results from the APS ACTION clinical database and repository 212
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases 201
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 200
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma 198
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 194
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies 190
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies 187
Antibodies Against Domain 1 and Domain 4/5 of β2 Glycoprotein I : Clinical Relevance in Obstetric Anti-Phospholipid Syndrome 183
Obstetric antiphospholipid syndrome: Lobsters only? or should we also look for selected red herrings? 182
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 182
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases 181
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity 181
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 180
Chronic nonbacterial osteomyelitis and inflammatory bowel disease: A literature review-based cohort 178
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study 178
The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registry 177
Anti-NR2 antibodies and primary antiphospholipid syndrome : a preliminary study 170
APS and the nervous system 168
Lung Disease in Antiphospholipid Syndrome 166
N-TproBNP as biomarker in systemic sclerosis 162
The Use of Cyclosporine A in Rheumatology : a 2016 Comprehensive Review 160
Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature 156
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers 154
Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome 154
Does APS Impact Women’s Fertility? 154
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking 153
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases) 152
Treatment of pregnancy complications 147
Chemerin serum levels in systemic sclerosis: a novel marker of early and active disease? 147
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 146
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases 146
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 143
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases 143
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis : a critical review of the literature 142
Relationship between sle susceptibility genes and clinical manifestations in a cohort of patients with primary antiphospholipid syndrome 141
14. International congress on antiphospholipid antibodies task force : report on obstetric antiphospholipid syndrome 141
Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic Arthritis 140
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction 140
Obstetric and vascular antiphospholipid syndrome: Same antibodies but different diseases? 139
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management 137
JAK inhibitors in the treatment of adult patients with juvenile idiopathic arthritis: a retrospective monocentric experience 136
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 134
14. International congress on antiphospholipid antibodies task force. Report on antiphospholipid syndrome laboratory diagnostics and trends 132
The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus 132
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 131
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No 131
An Altered Cardiovascular System Development Gene Expression Signature in Skin is a Hallmark of Limited Cutaneous Systemic Sclerosis 130
Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review 129
Role of N-terminal pro-BNP in detecting clinically-significant cardiac involvement in systemic sclerosis patients 129
The use of biologics and small molecules in pregnant patients with rheumatic diseases 129
Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies 128
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 128
Diagnostic and prognostic role of synovial tissue analysis in juvenile idiopathic arthritis: a monocentric study 126
Novel Mechanisms of Action of the Biologicals in Rheumatic Diseases 126
Antiphospholipid antibodies and infertility 125
Antiphospholipid antibody mechanisms of thrombosis 124
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 124
Anti-phospholipid antibodies and reproductive failures 123
Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis 119
New treatments 118
Serum chemerin in systemic sclerosis : a novel marker of early diffuse disease? 118
Antibodies and Diagnostic Tests in Antiphospholipid Syndrome 118
Update on the pathogenesis and treatment of the antiphospholipid syndrome 117
Pathophysiology of the antiphospholipid syndrome (APS) 116
β2-glycoprotein I, lipopolysaccharide and endothelial TLR4 : three players in the two hit theory for anti-phospholipid-mediated thrombosis 115
The challenges of lupus anticoagulants 115
The interplay between the antiphospholipid syndrome and systemic lupus erythematosus 113
Mechanisms of Action of the Antiphospholipid Antibodies 113
Systemic sclerosis : introduction 112
The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease 111
Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: Reply 111
Belimumab-induced periungual pyogenic granulomas: A case report 108
Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis 108
Anti-phospholipid Antibody Mechanisms of Thrombosis 107
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis 104
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview 103
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry 103
Anti-phosphatidylserine/prothrombin antibodies : an additional diagnostic marker for APS? 102
The SPROUT study: A survey on current management practice of reproductive aspects in women of childbearing age with systemic autoimmune rheumatic diseases 100
The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis : a critical review of the literature 100
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository Cluster Analysis : Identification of Different Clinical Phenotypes Among Antiphospholipid Antibody-Positive Female Patients 99
Toll like receptors : a crossroad in scleroderma etiopathogenesis 97
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 96
Totale 17.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 84 56 22 40 77 74 53 74 123 99 84 234
2022/20231.447 166 133 128 145 142 281 42 132 156 21 73 28
2023/20241.062 45 65 53 88 286 54 50 66 24 68 111 152
2024/20253.119 101 329 105 251 256 166 159 302 171 300 289 690
2025/20268.023 669 462 770 708 811 417 999 348 728 506 794 811
2026/2027215 215 0 0 0 0 0 0 0 0 0 0 0
Totale 20.004